Viewing nowCombinationTruStar Tablets 80/10 milligrams
Telmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 201504137 · Approved 2015.06.25 · Insurance code 650303390
Treatment of hypertension and dyslipidemia, inhibition of the progression of atherosclerosis, and prevention of cardiovascular disease
This medication is used for patients who need to take both telmisartan and rosuvastatin together. Telmisartan helps treat essential hypertension and reduces the cardiovascular disease risk in elderly patients who are at high risk for myocardial infarction or stroke. Rosuvastatin improves hypercholesterolemia or dyslipidemia that cannot be controlled through diet and exercise and slows the progression of atherosclerosis to reduce the risk of cardiovascular diseases. It particularly helps reduce the risk of stroke, myocardial infarction, and vascular revascularization in adults with cardiovascular disease risk factors. The combination therapy of these two components is used not only for the management of hypertension and hyperlipidemia but also to effectively reduce the risk of developing cardiovascular diseases and improve health.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan and rosuvastatin components. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. This medicine provides additional blood pressure reduction when administered in combination with a thiazide diuretic such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. 3. Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. This medicine may be taken at any time of the day, regardless of meals. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams per day. 2. Older adults: No dosage adjustment is required. 3. Patients with renal impairment: No dosage adjustment is required for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product with the same content of each active ingredient) for convenience.
This medication can cause serious harm to the fetus and newborn during pregnancy; therefore, if pregnancy is confirmed, it should be discontinued immediately. It should not be used in women who are allergic to this medication or its components, pregnant or nursing women, or fertile women who are not using effective contraception. Patients with severely impaired liver function or problems with bile excretion, and patients with unexplained elevations in liver enzymes should also avoid this medication. Patients with a history of muscle disease or hereditary angioedema, those with severe renal impairment, and patients taking certain immunosuppressants should not use this medication. Additionally, high-dose treatment with this medication is prohibited in diabetic patients whose renal function is moderately impaired or those at high risk for muscle disease. This medication contains lactose and should not be given to patients with genetic diseases such as lactose intolerance. Elderly patients, those with high potassium levels, and patients with slightly impaired liver function should use this medication with caution and have dose limitations. Patients with liver disease, hypothyroidism, certain heart valve diseases, and ischemic heart disease should also be closely monitored when administered. If symptoms such as muscle pain or weakness occur while taking this medication, consult a doctor immediately, and if necessary, check for muscle damage through blood tests. Liver function tests should also be performed regularly, and if signs of liver damage appear, administration should be stopped. The risk of side effects may increase when taken with other antihypertensive drugs or certain lipid-lowering agents, so the doctor should be informed of any other medications being used. Avoid excessive alcohol consumption during treatment and discuss any changes in exercise or other health conditions with healthcare professionals. Caution is needed when driving or operating machinery, as dizziness or drowsiness may occur. Finally, keep it out of the reach of children, and ensure that the container is not changed arbitrarily.
Headache, positional dizziness, sleep paralysis, blood pressure elevation, blood pressure reduction, hypotension, ALT elevation, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, gastrointestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory tract infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal distension, vomiting, abdominal discomfort, dry mouth, abnormal liver function, liver dysfunction, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendinopathy, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, elevated serum CK, decreased hemoglobin, angioedema, hypersensitivity reactions including angioedema, diabetes, constipation, nausea, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorder, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe myasthenia gravis, ocular myasthenia gravis, facial spasms, sensory disturbances, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, edema, facial edema, alopecia, conjunctivitis, tinnitus, petechiae, palpitations, fatigue, nausea, insufficient effect, cough, palpitations, myalgia, increased CK, constipation, increased AST, numbness, sensory disturbances, chest discomfort, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.
Bright blue oval film-coated tablet
30 tablets (10 tablets x 3 PTP)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.